Duopharma Biotech Bhd
KLSE:DPHARMA
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Estee Lauder Companies Inc
NYSE:EL
|
Consumer products
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Church & Dwight Co Inc
NYSE:CHD
|
Consumer products
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
American Express Co
NYSE:AXP
|
Financial Services
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Target Corp
NYSE:TGT
|
Retail
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
| US |
|
Mueller Industries Inc
NYSE:MLI
|
Machinery
|
| US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
1.13
1.4
|
| Price Target |
|
We'll email you a reminder when the closing price reaches MYR.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Estee Lauder Companies Inc
NYSE:EL
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Church & Dwight Co Inc
NYSE:CHD
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
American Express Co
NYSE:AXP
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Target Corp
NYSE:TGT
|
US |
|
|
Walt Disney Co
NYSE:DIS
|
US |
|
|
Mueller Industries Inc
NYSE:MLI
|
US |
|
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Duopharma Biotech Bhd
Current Portion of Long-Term Debt
Duopharma Biotech Bhd
Current Portion of Long-Term Debt Peer Comparison
Competitive Current Portion of Long-Term Debt Analysis
Latest Figures & CAGR of Competitors
| Company | Current Portion of Long-Term Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
D
|
Duopharma Biotech Bhd
KLSE:DPHARMA
|
Current Portion of Long-Term Debt
myr51.1m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
N/A
|
|
P
|
PeterLabs Holdings Bhd
KLSE:PLABS
|
Current Portion of Long-Term Debt
myr19.3m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
15%
|
CAGR 10-Years
28%
|
|
A
|
Apex Healthcare Bhd
KLSE:AHEALTH
|
Current Portion of Long-Term Debt
myr4.6m
|
CAGR 3-Years
-38%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
N/A
|
|
R
|
Rhone Ma Holdings Bhd
KLSE:RHONEMA
|
Current Portion of Long-Term Debt
myr4m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
|
Y
|
YSP Southeast Asia Holding Bhd
KLSE:YSPSAH
|
Current Portion of Long-Term Debt
myr16.2m
|
CAGR 3-Years
1%
|
CAGR 5-Years
5%
|
CAGR 10-Years
1%
|
|
K
|
Kotra Industries Bhd
KLSE:KOTRA
|
Current Portion of Long-Term Debt
myr244k
|
CAGR 3-Years
-73%
|
CAGR 5-Years
-55%
|
CAGR 10-Years
-40%
|
See Also
What is Duopharma Biotech Bhd's Current Portion of Long-Term Debt?
Current Portion of Long-Term Debt
51.1m
MYR
Based on the financial report for Jun 30, 2024, Duopharma Biotech Bhd's Current Portion of Long-Term Debt amounts to 51.1m MYR.
What is Duopharma Biotech Bhd's Current Portion of Long-Term Debt growth rate?
Current Portion of Long-Term Debt CAGR 5Y
-17%
Over the last year, the Current Portion of Long-Term Debt growth was -69%. The average annual Current Portion of Long-Term Debt growth rates for Duopharma Biotech Bhd have been -8% over the past three years , -17% over the past five years .
You don't have any saved screeners yet
